-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the "Liver Cancer Prevention and Control Research Center" and the National Health and Health Administration Hospital Management Institute ,"a standardized training project demonstration project for primary liver cancer diagnosis and treatment" was established at Tianjin Medical University Cancer Hospital.
China is a major liver cancer country, with about 59% of new cases worldwide each year. Although new treatments such as targeted drugs and immunotherapy have brought more solutions to the treatment of liver cancer, the progress of liver cancer treatment is still slow. At present, the diagnosis and treatment of liver cancer still faces the difficulty of early diagnosis, high rate of recurrence metastasis, radiation chemotherapy tolerance and lack of effective treatment targets. Therefore, it is of great significance to establish a research center for liver cancer prevention and treatment in one integrated basic research, applied research, technological innovation and product development.
"Liver Cancer Prevention and Control Research Center" relying on the Tianjin Medical University Cancer Hospital discipline platform, patient-centered, in order to achieve liver cancer prevention and early diagnosis and individualization, standardized multidisciplinary consultation and treatment (MDT) as the goal, to create a "precision prevention and treatment" model of liver cancer, so that patients in a short period of time to obtain individual treatment options.At the same time,
the center will closely combine basic research, transformation al-china research and clinical research on liver cancer, build an innovative mechanism of close cooperation between production, learning and research, and build a new system for the transformation of comprehensive prevention and treatment of liver cancer, so as to realize the real application of scientific research results to the clinic.Professor Lu Wei, party secretary of Tianjin Medical University Cancer Hospital and director of the Liver Cancer Prevention and Control Research Center, said, "The Center for The Prevention and Control of Liver Cancer" will focus on the goal of "reducing the incidence and mortality of liver cancer in China" and carry out high-level basic and clinical application research in the areas including early diagnosis and prognosis of liver cancer, immunotherapy of liver cancer, molecular control network of liver cancer, and clinical data analysis of liver cancer.
Professor Song Tianqiang, director of the Department of Hepatobiliary Oncology at Tianjin Medical University Cancer Hospital and executive director of the Center for The Prevention and Control of Liver Cancer, also expressed the need to further strengthen the close cooperation of the departments of liver cancer-related clinics such as surgery, intervention, internal medicine, radiotherapy, ultrasound, pathology and imaging. At the same time, we will strengthen the popular science publicity for the prevention and treatment of liver cancer, establish and promote the "prevention-diagnosis-treatment" planning management system for liver cancer, and enhance the public's awareness of liver cancer.
in addition, the standardized training project for primary liver cancer diagnosis and treatment in 2018 by the National Health and Care Commission Hospital Management Research Institute, through the "primary liver cancer diagnosis and treatment norms (2017 edition)" publicity and training, to promote medical institutions in accordance with the requirements of the norms, master standardized means of diagnosis and treatment, to provide patients with standardized medical services.
project will establish 10 standardized diagnosis and treatment demonstration bases and more than 20 test bases nationwide from 2018 to 2019. Tianjin Medical University Cancer Hospital, as a demonstration base, will, through demonstration effect, to demonstration teaching, academic seminars, network exchanges and other forms, to drive and affect the demonstration base around the medical institutions of liver cancer standardization diagnosis and treatment work, improve the medical personnel's ability to diagnose and treat. (Tianjin Cancer Hospital Yang Yang)
.